1/9
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Class
Anti-platelet agents, non-opioid, analgesic, non-steroidal anti-inflammatory drugs (NSAIDs)
Action
Produce analgesia and reduce fever by inhibiting prostaglandin production.
Decreases platelet aggregation.
Therapeutic Effects
Analgesia, reduced, inflammation, reduced fever.
Decreased incident of transient ischemic attacks and MI.
Adverse Reactions/Side Effects
Nausea, abdominal pain, dyspepsia, epigastric distress, G.I. bleeding, hepatotoxicity
Route/Dosage
Prevention of MI/antiplatelet effects:
PO: 80 - 325mg once daily
Suspected acute MI: 160mg as soon as suspicion occurs
Contraindications/Precautions
Hypersensitivity, bleeding disorders, or thrombocytopenia, cross sensitivity with other NSAIDs
Interactions
Heparin like agents, thrombolytic agents:
May increase risk of bleeding
Ibuprofen:
May negate cardioprotective antiplatelet effects of low-dose aspirin
Nursing Implications/Implementation
Monitor for S/S of DRESS (drug reaction with eosinophilia and systemic symptoms)
Asthma, allergies, nasal polyps, and allergies to tartrazine are at increased risk of hypersensitivity reaction.
Use lowest effective dose for shortest period of time.
Evaluation/Desired Outcomes
Relief of mild to moderate discomfort.
Prevention of MI.
Prevention of transient ischemic attacks.
Reduction of fever.
Patient/Family Teaching
Take with full glass of water, and remain in the upright position for 15-30 minutes after.
Advised to report, tinnitus, unusual gum bleeding, black/tarry stool, fever greater than three days
Avoid alcohol to minimize, G.I. irritation, and risk of G.I. bleed